Established in April 2003, BioNime engages in the leading business of biotechnology and medical testing. Concerning medical testing, it can be further categorized into reagent and testing equipment.
If only we can integrate technology in different fields, such as medical science, biochemistry, and precision instruments, we believe we have the opportunity of making innovation and success.
Our management team is formed by integrating professionals from different venues: the experts from electronic business with more than twenty years of experience, famous electrochemistry labs in the field of medicine in Taiwan and overseas, and professional managers and designers from famous domestic companies. With unique patented technology and production processes, they integrate the lastest expertise in medical science, chemistry, electronics, systems, precision instruments, and the latest nano-technology. In October 2003, pilot run, which creates a new generation of sensor structure. In addition, it has gone beyond the limits of huge manufacturers that have hundreds of patents to accomplish the competitive advantages of high accuracy, high stability and enhanced products. The core technology patent has been granted in 2006. Moreover, more than 15 technology and design patents are going to be granted or under verifying. At present, BIONIME has possessed the capacity to compete and cooperate with the first-rate manufacturers in the world.
Employing the advantages of the R&D & manufacturing of electronics in Taiwan and the exquisite design in Switzerland, Bionime integrates expertise in biochemistry, medicine and electronics, to manufacture products with smart applications. Regarding Taiwan as the base, BIONIME targets Europe, America and Mainland China as its major markets. With its base solidly established in Taiwan, BIONIME intends to open up markets worldwide. In order to get close to the markets of Europe and America, BIONIME will keep setting up the overseas branches in Europe and America to develop the markets there.
At BIONIME ,we are committed to developing bio-sensors. Indeed,we are dedicated to develop innovative BIO -sensors by applying N ano-technology in the modification of either I njection M olding E lectrode or I nsertion M odified E lectrode — the heart of BIONIME biosensors.
Bionime(华广生技)
Established in April 2003, BioNime engages in the leading business of biotechnology and medical testing. Concerning medical testing, it can be further categorized into reagent and testing equipment.
If only we can integrate technology in different fields, such as medical science, biochemistry, and precision instruments, we believe we have the opportunity of making innovation and success.
Our management team is formed by integrating professionals from different venues: the experts from electronic business with more than twenty years of experience, famous electrochemistry labs in the field of medicine in Taiwan and overseas, and professional managers and designers from famous domestic companies. With unique patented technology and production processes, they integrate the lastest expertise in medical science, chemistry, electronics, systems, precision instruments, and the latest nano-technology. In October 2003, pilot run, which creates a new generation of sensor structure. In addition, it has gone beyond the limits of huge manufacturers that have hundreds of patents to accomplish the competitive advantages of high accuracy, high stability and enhanced products. The core technology patent has been granted in 2006. Moreover, more than 15 technology and design patents are going to be granted or under verifying. At present, BIONIME has possessed the capacity to compete and cooperate with the first-rate manufacturers in the world.
Employing the advantages of the R&D & manufacturing of electronics in Taiwan and the exquisite design in Switzerland, Bionime integrates expertise in biochemistry, medicine and electronics, to manufacture products with smart applications. Regarding Taiwan as the base, BIONIME targets Europe, America and Mainland China as its major markets. With its base solidly established in Taiwan, BIONIME intends to open up markets worldwide. In order to get close to the markets of Europe and America, BIONIME will keep setting up the overseas branches in Europe and America to develop the markets there.
At BIONIME ,we are committed to developing bio-sensors. Indeed,we are dedicated to develop innovative BIO -sensors by applying N ano-technology in the modification of either I njection M olding E lectrode or I nsertion M odified E lectrode — the heart of BIONIME biosensors.